17d
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications ...
The translation of biomarker discoveries into diagnostic applications relies on the robustness of clinical proteomics. Achieving high-throughput, reproducible results requires careful attention to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results